Cibc Private Wealth Group, LLC Halozyme Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 4,046 shares of HALO stock, worth $216,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,046
Previous 3,053
32.53%
Holding current value
$216,663
Previous $145,000
77.93%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$944 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$687 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$324 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$209 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$197 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.46B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...